Minocycline Hydrochloride Tablet, Film Coated, Extended Release
NDC Package 72789-528-30
Package Information
Minocycline Hydrochloride tablets is a medication contraindicated in persons who have shown hypersensitivity to any of the tetracyclines. This formulation utilizes a tablet, film coated, extended release delivery system. Marketed by Pd-rx Pharmaceuticals, Inc., this product is identified by NDC 72789-528 and is authorized under FDA application ANDA204453.
Identification & Billing
- RxCUI: 1013659 - minocycline HCl 105 MG 24HR Extended Release Oral Tablet
- RxCUI: 1013659 - 24 HR minocycline 105 MG Extended Release Oral Tablet
- RxCUI: 1013659 - minocycline 105 MG (26.25 MG Immediate Release Beads / 78.75 MG Extended Release Beads) 24 HR Extended Release Oral Tablet
- RxCUI: 1013659 - minocycline 105 MG (as minocycline HCl 113.4 MG) 24 HR Extended Release Oral Tablet
- RxCUI: 1013659 - minocycline 105 MG 24 HR Extended Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72789 - Pd-rx Pharmaceuticals, Inc.
- 72789-528 - Minocycline Hydrochloride
- 72789-528-30 - 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
- 72789-528 - Minocycline Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72789-528-30 identifies a specific commercial package of 30 tablet, film coated, extended release in 1 bottle, plastic of Minocycline Hydrochloride, a human prescription drug labeled by Pd-rx Pharmaceuticals, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This tablet, film coated, extended release is formulated for oral use and contains minocycline hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pd-rx Pharmaceuticals, Inc. on September 30, 2016. The current certification is valid through December 31, 2026.
How is this Pd-rx Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72789052830. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.